Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML)

Attique Samdani, Ujjwala Vijapurkar, Martha A. Grimm, Catherine S Perry, Thomas M. Grogan, Betty J. Glinsmann-Gibson, Alan F. List

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Clinical and biological features have recognized prognostic significance in acute myeloid leukemia (AML). To evaluate the interaction of these variables and weighted effect on treatment outcome, prognostic variables from 96 previously untreated patients were analyzed for association with expression of the MDR1 gene product P-glycoprotein (Pgp), and effect on response to induction chemotherapy, progression-free survival and overall survival. Multivariate relationships were analyzed using six prognostic variables, including age, cytogenetic pattern, gender, CD34+ surface phenotype, AML type (de novo versus secondary) and Pgp. Univariate comparisons indicate that Pgp (P = 0.0001), cytogenetic pattern (P = 0.0004) and a CD34+ phenotype (P = 0.0005) are predictive of primary treatment failure, whereas Pgp (P = 0.0001) had the greatest predictive value in multivariate analysis. Only cytogenetic pattern retained prognostic significance (P = 0.0143) for response to induction therapy after adjustment for Pgp. Although all variables except gender were associated with Pgp, specimens harboring the favorable karyotypic abnormalities t(15;17), t(8;21) and inv(16) exclusively lacked Pgp expression. In a multivariate model, both Pgp and cytogenetic pattern predicted response and overall survival, whereas secondary AML and cytogenetic pattern influenced remission duration. These findings indicate that cytogenetic pattern has prognostic relevance that is independent of Pgp, and implies the presence of undefined biological mechanisms affecting chemotherapy resistance.

Original languageEnglish (US)
Pages (from-to)175-180
Number of pages6
JournalLeukemia Research
Volume20
Issue number2
DOIs
StatePublished - Feb 1996

Fingerprint

P-Glycoprotein
Acute Myeloid Leukemia
Cytogenetics
Phenotype
Induction Chemotherapy
Survival
Treatment Failure
Disease-Free Survival
Multivariate Analysis
Gene Expression
Drug Therapy

Keywords

  • AML
  • CD-34
  • Cytogenetics
  • P-glycoprotein

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML). / Samdani, Attique; Vijapurkar, Ujjwala; Grimm, Martha A.; Perry, Catherine S; Grogan, Thomas M.; Glinsmann-Gibson, Betty J.; List, Alan F.

In: Leukemia Research, Vol. 20, No. 2, 02.1996, p. 175-180.

Research output: Contribution to journalArticle

Samdani, Attique ; Vijapurkar, Ujjwala ; Grimm, Martha A. ; Perry, Catherine S ; Grogan, Thomas M. ; Glinsmann-Gibson, Betty J. ; List, Alan F. / Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML). In: Leukemia Research. 1996 ; Vol. 20, No. 2. pp. 175-180.
@article{f372b60d980f4e55856c672a44ceb6aa,
title = "Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML)",
abstract = "Clinical and biological features have recognized prognostic significance in acute myeloid leukemia (AML). To evaluate the interaction of these variables and weighted effect on treatment outcome, prognostic variables from 96 previously untreated patients were analyzed for association with expression of the MDR1 gene product P-glycoprotein (Pgp), and effect on response to induction chemotherapy, progression-free survival and overall survival. Multivariate relationships were analyzed using six prognostic variables, including age, cytogenetic pattern, gender, CD34+ surface phenotype, AML type (de novo versus secondary) and Pgp. Univariate comparisons indicate that Pgp (P = 0.0001), cytogenetic pattern (P = 0.0004) and a CD34+ phenotype (P = 0.0005) are predictive of primary treatment failure, whereas Pgp (P = 0.0001) had the greatest predictive value in multivariate analysis. Only cytogenetic pattern retained prognostic significance (P = 0.0143) for response to induction therapy after adjustment for Pgp. Although all variables except gender were associated with Pgp, specimens harboring the favorable karyotypic abnormalities t(15;17), t(8;21) and inv(16) exclusively lacked Pgp expression. In a multivariate model, both Pgp and cytogenetic pattern predicted response and overall survival, whereas secondary AML and cytogenetic pattern influenced remission duration. These findings indicate that cytogenetic pattern has prognostic relevance that is independent of Pgp, and implies the presence of undefined biological mechanisms affecting chemotherapy resistance.",
keywords = "AML, CD-34, Cytogenetics, P-glycoprotein",
author = "Attique Samdani and Ujjwala Vijapurkar and Grimm, {Martha A.} and Perry, {Catherine S} and Grogan, {Thomas M.} and Glinsmann-Gibson, {Betty J.} and List, {Alan F.}",
year = "1996",
month = "2",
doi = "10.1016/0145-2126(95)00134-4",
language = "English (US)",
volume = "20",
pages = "175--180",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML)

AU - Samdani, Attique

AU - Vijapurkar, Ujjwala

AU - Grimm, Martha A.

AU - Perry, Catherine S

AU - Grogan, Thomas M.

AU - Glinsmann-Gibson, Betty J.

AU - List, Alan F.

PY - 1996/2

Y1 - 1996/2

N2 - Clinical and biological features have recognized prognostic significance in acute myeloid leukemia (AML). To evaluate the interaction of these variables and weighted effect on treatment outcome, prognostic variables from 96 previously untreated patients were analyzed for association with expression of the MDR1 gene product P-glycoprotein (Pgp), and effect on response to induction chemotherapy, progression-free survival and overall survival. Multivariate relationships were analyzed using six prognostic variables, including age, cytogenetic pattern, gender, CD34+ surface phenotype, AML type (de novo versus secondary) and Pgp. Univariate comparisons indicate that Pgp (P = 0.0001), cytogenetic pattern (P = 0.0004) and a CD34+ phenotype (P = 0.0005) are predictive of primary treatment failure, whereas Pgp (P = 0.0001) had the greatest predictive value in multivariate analysis. Only cytogenetic pattern retained prognostic significance (P = 0.0143) for response to induction therapy after adjustment for Pgp. Although all variables except gender were associated with Pgp, specimens harboring the favorable karyotypic abnormalities t(15;17), t(8;21) and inv(16) exclusively lacked Pgp expression. In a multivariate model, both Pgp and cytogenetic pattern predicted response and overall survival, whereas secondary AML and cytogenetic pattern influenced remission duration. These findings indicate that cytogenetic pattern has prognostic relevance that is independent of Pgp, and implies the presence of undefined biological mechanisms affecting chemotherapy resistance.

AB - Clinical and biological features have recognized prognostic significance in acute myeloid leukemia (AML). To evaluate the interaction of these variables and weighted effect on treatment outcome, prognostic variables from 96 previously untreated patients were analyzed for association with expression of the MDR1 gene product P-glycoprotein (Pgp), and effect on response to induction chemotherapy, progression-free survival and overall survival. Multivariate relationships were analyzed using six prognostic variables, including age, cytogenetic pattern, gender, CD34+ surface phenotype, AML type (de novo versus secondary) and Pgp. Univariate comparisons indicate that Pgp (P = 0.0001), cytogenetic pattern (P = 0.0004) and a CD34+ phenotype (P = 0.0005) are predictive of primary treatment failure, whereas Pgp (P = 0.0001) had the greatest predictive value in multivariate analysis. Only cytogenetic pattern retained prognostic significance (P = 0.0143) for response to induction therapy after adjustment for Pgp. Although all variables except gender were associated with Pgp, specimens harboring the favorable karyotypic abnormalities t(15;17), t(8;21) and inv(16) exclusively lacked Pgp expression. In a multivariate model, both Pgp and cytogenetic pattern predicted response and overall survival, whereas secondary AML and cytogenetic pattern influenced remission duration. These findings indicate that cytogenetic pattern has prognostic relevance that is independent of Pgp, and implies the presence of undefined biological mechanisms affecting chemotherapy resistance.

KW - AML

KW - CD-34

KW - Cytogenetics

KW - P-glycoprotein

UR - http://www.scopus.com/inward/record.url?scp=0029869917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029869917&partnerID=8YFLogxK

U2 - 10.1016/0145-2126(95)00134-4

DO - 10.1016/0145-2126(95)00134-4

M3 - Article

C2 - 8628017

AN - SCOPUS:0029869917

VL - 20

SP - 175

EP - 180

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 2

ER -